Joseph G. Parambil

Joseph G. Parambil

Pulmonary Medicine
2049 East 100th Street
Cleveland, OH 44106

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Endotypes of Vascular Health Predict Transplantation-Free Survival in Pulmonary Hypertension.

Endotypes of Vascular Health Predict Transplantation-Free Survival in Pulmonary Hypertension.

Journal: Journal of the American Heart Association
Published: July 17, 2026

Clinical spectrum of hereditary hemorrhagic telangiectasia: data from the Comprehensive HHT Outcomes Registry of the US (CHORUS).

Clinical spectrum of hereditary hemorrhagic telangiectasia: data from the Comprehensive HHT Outcomes Registry of the US (CHORUS).

Journal: Blood
Published: January 07, 2026

Clinical Spectrum of Hereditary Hemorrhagic Telangiectasia: Data from the Comprehensive HHT Outcomes Registry of the US (CHORUS).

Clinical Spectrum of Hereditary Hemorrhagic Telangiectasia: Data from the Comprehensive HHT Outcomes Registry of the US (CHORUS).

Journal: Blood
Published: January 07, 2026

Characteristics associated with clinical response to pomalidomide in hereditary hemorrhagic telangiectasia.

Characteristics associated with clinical response to pomalidomide in hereditary hemorrhagic telangiectasia.

Journal: Blood advances
Published: December 23, 2025

Characteristics Associated with Clinical Response to Pomalidomide in Hereditary Hemorrhagic Telangiectasia.

Characteristics Associated with Clinical Response to Pomalidomide in Hereditary Hemorrhagic Telangiectasia.

Journal: Blood advances
Published: December 23, 2025

Left Atrial Appendage Occlusion in Patients With Hereditary Hemorrhagic Telangiectasia and Atrial Fibrillation.

Left Atrial Appendage Occlusion in Patients With Hereditary Hemorrhagic Telangiectasia and Atrial Fibrillation.

Journal: JACC. Clinical electrophysiology
Published: November 17, 2025

Pomalidomide for Hereditary Hemorrhagic Telangiectasia: After Trial Longitudinal Assessment Study (PATH-HHT ATLAS).

Pomalidomide for Hereditary Hemorrhagic Telangiectasia: After Trial Longitudinal Assessment Study (PATH-HHT ATLAS).

Journal: Blood advances
Published: September 10, 2025

Pomalidomide for hereditary hemorrhagic telangiectasia: after trial longitudinal assessment study (PATH-HHT ATLAS).

Pomalidomide for hereditary hemorrhagic telangiectasia: after trial longitudinal assessment study (PATH-HHT ATLAS).

Journal: Blood advances
Published: September 10, 2025

Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scale.

Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scale.

Journal: Journal of thrombosis and haemostasis : JTH
Published: May 06, 2025

A rare case of bilateral rectus sheath hematoma due to anticoagulation: An abdominal CT scan revelation.

A rare case of bilateral rectus sheath hematoma due to anticoagulation: An abdominal CT scan revelation.

Journal: Radiology case reports
Published: May 04, 2025

Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia.

Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia.

Journal: The New England journal of medicine
Published: September 18, 2024

Interstitial Lung Abnormality: Narrative Review of the Approach to Diagnosis and Management.

Interstitial Lung Abnormality: Narrative Review of the Approach to Diagnosis and Management.

Journal: Chest
Published: May 16, 2024
Showing 1-12 of 35

Last Updated: 09/26/2026